Search Login Register

3,9-bis((ethylthio)methyl)-K-252a Summary

Description: RN given for (9S-(9alpha,10beta,12alpha))-isomer; mixed lineage kinase inhibitor, neuroprotective agent, and neurotrophic agent derived from K-252a; structure in first source

Also Known As: 3,9-bis(EtSM)-K-252a; CEP 1347; CEP-1347; CEP1347; KT 7515 Show All >>

Networked: 31 relevant articles (2 outcomes, 7 trials/studies) for this Bio-Agent

Key Diseases for which 3,9-bis((ethylthio)methyl)-K-252a is Relevant

  1. Ischemia : 1 outcome 1 study in 1 result
  2. Anoxia (Hypoxia) : 1 outcome 1 study in 1 result
  3. Pancreatitis : 1 outcome in 2 results
  4. Parkinson Disease (Parkinson's Disease) : 4 studies in 8 results
  5. Parkinsonian Disorders (Parkinsonism) : 3 studies in 3 results
Show All >>

Drugs Related to 3,9-bis((ethylthio)methyl)-K-252a

  1. Caerulein (Ceruletide)
  2. Selegiline (E250)
  3. Phosphotransferases (Kinase)
  4. Brain-Derived Neurotrophic Factor (BDNF)
  5. Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)
  6. Uric Acid (Urate)
  7. 3,9-bis((ethylthio)methyl)-K-252a
  8. JNK Mitogen-Activated Protein Kinases
  9. 1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)
  10. SB 203580
Show All >>

Therapies Related to 3,9-bis((ethylthio)methyl)-K-252a

  1. Intraperitoneal Injections

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.